{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T12:51:18Z","timestamp":1789390278882,"version":"build-2803163510"},"reference-count":64,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,10,8]],"date-time":"2020-10-08T00:00:00Z","timestamp":1602115200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","cmghjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular and Molecular Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2021]]},"DOI":"10.1016\/j.jcmgh.2020.10.001","type":"journal-article","created":{"date-parts":[[2020,10,13]],"date-time":"2020-10-13T22:32:19Z","timestamp":1602628339000},"page":"841-855","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Impaired Duodenal Palmitoylethanolamide Release Underlies Acid-Induced Mast Cell Activation in Functional Dyspepsia"],"prefix":"10.1016","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1467-1134","authenticated-orcid":false,"given":"Giovanni","family":"Sarnelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5996-4259","authenticated-orcid":false,"given":"Marcella","family":"Pesce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luisa","family":"Seguella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora","family":"Efficie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Tack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatima Domenica","family":"Elisa De Palma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"D\u2019Alessandro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Esposito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jcmgh.2020.10.001_bib1","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/nrgastro.2013.14","article-title":"Functional dyspepsia--symptoms, definitions and validity of the Rome III criteria","volume":"10","author":"Tack","year":"2013","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jcmgh.2020.10.001_bib2","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1053\/j.gastro.2005.11.059","article-title":"Functional gastroduodenal disorders","volume":"130","author":"Tack","year":"2006","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.jcmgh.2020.10.001_bib3","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/nrgastro.2013.11","article-title":"Current management strategies and emerging treatments for functional dyspepsia","volume":"10","author":"Camilleri","year":"2013","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.jcmgh.2020.10.001_bib4","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1053\/j.gastro.2004.05.030","article-title":"Pathophysiology and treatment of functional dyspepsia","volume":"127","author":"Tack","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jcmgh.2020.10.001_bib5","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1038\/nrgastro.2012.255","article-title":"Changes in gastrointestinal tract function and structure in functional dyspepsia","volume":"10","author":"Vanheel","year":"2013","journal-title":"Nat. Rev. Gastroenterol. Hepatol"},{"issue":"3 July","key":"10.1016\/j.jcmgh.2020.10.001_bib6","article-title":"Duodenal Implications in the Pathophysiology of Functional Dyspepsia","volume":"16","author":"Lee","year":"2010","journal-title":"J Neurogastroenterol Motil"},{"issue":"3 July","key":"10.1016\/j.jcmgh.2020.10.001_bib7","article-title":"Role of the Duodenum in the Pathogenesis of Functional Dyspepsia: A Paradigm Shift","volume":"24","author":"Jung","year":"2018","journal-title":"J Neurogastroenterol Motil"},{"key":"10.1016\/j.jcmgh.2020.10.001_bib8","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1046\/j.1365-2036.1998.00410.x","article-title":"Efficacy of omeprazole in functional dyspepsia: double-blind, randomized, placebo-controlled trials [the Bond and Opera studies]","volume":"12","author":"Talley","year":"1998","journal-title":"Aliment Pharmacol Ther"},{"issue":"6","key":"10.1016\/j.jcmgh.2020.10.001_bib9","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1177\/2050640613510904","article-title":"Effect of lansoprazole on the epigastric symptoms\u00a0of functional dyspepsia (ELF study): A multicentre, prospective, randomized, double-blind, placebo-controlled clinical trial","volume":"1","author":"Suzuki","year":"2013","journal-title":"United European Gastroenterol J"},{"key":"10.1016\/j.jcmgh.2020.10.001_bib10","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1046\/j.1365-2036.2001.01123.x","article-title":"Effect of inhibition of gastric acid secretion on antropyloroduodenal motor activity and duodenal acid hypersensitivity in functional dyspepsia","volume":"15","author":"Schwarz","year":"2001","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jcmgh.2020.10.001_bib11","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/S0016-5085(99)70171-X","article-title":"Abnormal clearance of exogenous acid and increased acid sensitivity of the proximal duodenum in dyspeptic patients","volume":"116","author":"Samsom","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jcmgh.2020.10.001_bib12","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.1111\/j.1572-0241.2001.04103.x","article-title":"Chemospecific alterations in duodenal perception and motor response in functional dyspepsia","volume":"96","author":"Schwarz","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jcmgh.2020.10.001_bib13","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1111\/j.1572-0241.2004.30822.x","article-title":"Tack JA pilot study on duodenal acid exposure and its relationship to symptoms in functional dyspepsia with prominent nausea","volume":"99","author":"Lee","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jcmgh.2020.10.001_bib14","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/MCG.0b013e31818e37ab","article-title":"Prolonged recording of duodenal acid exposure in patients with functional dyspepsia and controls using a radiotelemetry pH monitoring system","volume":"43","author":"Bratten","year":"2009","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.jcmgh.2020.10.001_bib15","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1111\/j.1365-2982.2009.01274.x","article-title":"Prolonged duodenal acid perfusion and dyspeptic symptom occurrence in healthy volunteers","volume":"21","author":"di Stefano","year":"2009","journal-title":"Neurogastroenterol Motil"},{"issue":"10","key":"10.1016\/j.jcmgh.2020.10.001_bib16","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1155\/2000\/438981","article-title":"Acid-induced esophageal shortening in humans: A cause of hiatus hernia?","volume":"14","author":"Dunne","year":"2000","journal-title":"Can J Gastroenterol"},{"key":"10.1016\/j.jcmgh.2020.10.001_bib17","first-page":"G219","article-title":"Morphological evidence of mast cell degranulation in an animal model of acid-induced esophageal mucosal injury","volume":"269","author":"Barclay","year":"1995","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jcmgh.2020.10.001_bib18","doi-asserted-by":"crossref","first-page":"S52","DOI":"10.1016\/S0016-5085(20)30813-1","article-title":"Proton pump inhibitors reduce duodenal eosinophilia and symptoms in functional dyspepsia patients by anti-inflammatory rather than acid-suppressive effects abstract DDW 2020, in press","volume":"158","author":"Wauters","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jcmgh.2020.10.001_bib19","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.biochi.2010.01.006","article-title":"N-palmitoyl-ethanolamine: Biochemistry and new therapeutic opportunities","volume":"92","author":"Petrosino","year":"2010","journal-title":"Biochimie"},{"key":"10.1016\/j.jcmgh.2020.10.001_bib20","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.coph.2018.08.009","article-title":"Endocannabinoids in the treatment of gastrointestinal inflammation and symptoms","volume":"43","author":"Pesce","year":"2018","journal-title":"Current Opinion in Pharmacology"},{"issue":"2","key":"10.1016\/j.jcmgh.2020.10.001_bib21","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1111\/jcmm.13359","article-title":"Endocannabinoid-related compounds in gastrointestinal diseases","volume":"22","author":"Pesce","year":"2018","journal-title":"J. Cell. Mol. Med"},{"key":"10.1016\/j.jcmgh.2020.10.001_bib22","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3389\/fphar.2014.00028","article-title":"Targeting the endogenous cannabinoid system to treat neuropathic pain","volume":"5","author":"Lau","year":"2014","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jcmgh.2020.10.001_bib23","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0006-2952(01)00712-2","article-title":"Fatty acid amide hydrolase: biochemistry, pharmacology, and therapeutic possibilities for an enzyme hydrolyzing anandamide, 2-arachidonoylglycerol, palmitoylethanolamide, and oleamide","volume":"62","author":"Fowler","year":"2001","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.jcmgh.2020.10.001_bib24","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S1367-5931(03)00079-6","article-title":"Fatty acid amide hydrolase: an emerging therapeutic target in the endocannabinoid system","volume":"7","author":"Cravatt","year":"2003","journal-title":"Curr Opin Chem Biol"},{"key":"10.1016\/j.jcmgh.2020.10.001_bib25","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/BF01972748","article-title":"A proposed autacoid mechanism controlling mastocyte behaviour","volume":"39","author":"Aloe","year":"1993","journal-title":"Agents Action"},{"key":"10.1016\/j.jcmgh.2020.10.001_bib26","doi-asserted-by":"crossref","first-page":"3376","DOI":"10.1073\/pnas.92.8.3376","article-title":"Mast cells express a peripheral cannabinoid receptor with differential sensitivity to anandamide and palmitoylethanolamide","volume":"92","author":"Facci","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jcmgh.2020.10.001_bib27","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1038\/bjp.2008.324","article-title":"\u2018Entourage\u2019 effects of Npalmitoylethanolamide and N-oleoylethanolamide on vasorelaxation to anandamide occur through TRPV1 receptors","volume":"155","author":"Ho","year":"2008","journal-title":"Br J Pharmacol"},{"issue":"1","key":"10.1016\/j.jcmgh.2020.10.001_bib28","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1124\/mol.104.006353","article-title":"The nuclear receptor peroxisome proliferator-activated receptor-alpha mediates the anti-inflammatory actions of palmitoylethanolamide","volume":"67","author":"Lo Verme","year":"2005","journal-title":"Mol Pharmacol"},{"issue":"12","key":"10.1016\/j.jcmgh.2020.10.001_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0085073","article-title":"Endocannabinoid and Cannabinoid-Like Fatty Acid Amide Levels Correlate with Pain-Related Symptoms in Patients with IBS-D and IBS-C: A Pilot Study","volume":"8","author":"Fichna","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jcmgh.2020.10.001_bib30","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/978-3-540-34891-7_27","article-title":"Link between TRPV channels and mast cell function","volume":"179","author":"Turner","year":"2007","journal-title":"Handb. Exp. Pharmacol"},{"issue":"8","key":"10.1016\/j.jcmgh.2020.10.001_bib31","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1136\/gutjnl-2013-305005","article-title":"Palmitoylethanolamide improves colon inflammation through an enteric glia\/toll like receptor 4-dependent PPAR-\u03b1 activation","volume":"63","author":"Esposito","year":"2014","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.jcmgh.2020.10.001_bib32","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/ajg.2010.100","article-title":"Role of chemical of the duodenum in dyspeptic symptom generation","volume":"105","author":"van Boxel","year":"2010","journal-title":"Am J Gastroenterol"},{"issue":"12","key":"10.1016\/j.jcmgh.2020.10.001_bib33","doi-asserted-by":"crossref","first-page":"3108","DOI":"10.1002\/eji.201343782","article-title":"Mucosal innate immune\u00a0cells regulate both gut homeostasis and intestinal inflammation","volume":"43","author":"Kurashima","year":"2013","journal-title":"Eur J Immunol"},{"issue":"3","key":"10.1016\/j.jcmgh.2020.10.001_bib34","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1053\/j.gastro.2003.11.055","article-title":"Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome","volume":"126","author":"Barbara","year":"2004","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.jcmgh.2020.10.001_bib35","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1053\/j.gastro.2006.11.039","article-title":"Mast cell-dependent excitation of visceral-nociceptive sensory neurons in irritable bowel syndrome","volume":"132","author":"Barbara","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jcmgh.2020.10.001_bib36","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1053\/j.gastro.2004.02.017","article-title":"Enteric neuroimmunophysiology and pathophysiology","volume":"127","author":"Wood","year":"2004","journal-title":"Gastroenterology"},{"issue":"Pt 2","key":"10.1016\/j.jcmgh.2020.10.001_bib37","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1113\/jphysiol.2002.032011","article-title":"Mast cell tryptase and proteinase-activated receptor 2 induce hyperexcitability of guinea-pig submucosal neurons","volume":"547","author":"Reed","year":"2003","journal-title":"J Physiol"},{"key":"10.1016\/j.jcmgh.2020.10.001_bib38","article-title":"Mast cells: Versatile gatekeepers of pain","author":"Chatterjea","year":"2014","journal-title":"Mol Immunol"},{"issue":"4","key":"10.1016\/j.jcmgh.2020.10.001_bib39","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1053\/j.gastro.2013.01.040","article-title":"Functions and imaging of mast cell and neural axis of the gut","volume":"144","author":"Schemann","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jcmgh.2020.10.001_bib40","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.bbadis.2011.06.004","article-title":"Mast cell\u2013nerve axis with a focus on the human gut","author":"Buhner","year":"2012","journal-title":"Biochimica et Biophysica Acta 1822"},{"key":"10.1016\/j.jcmgh.2020.10.001_bib41","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.autneu.2006.02.025","article-title":"Enteric neuroplasticity evoked by inflammation","volume":"126-127","author":"Vasina","year":"2006","journal-title":"Autonomic Neuroscience"},{"issue":"1","key":"10.1016\/j.jcmgh.2020.10.001_bib42","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.brainresrev.2008.12.004","article-title":"Development, plasticity and modulation of visceral afferents","volume":"60","author":"Christianson","year":"2009","journal-title":"Brain Res Rev"},{"issue":"4","key":"10.1016\/j.jcmgh.2020.10.001_bib43","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1111\/j.1476-5381.2011.01601.x","article-title":"The thermo-TRP ion channel family: properties and therapeutic implications","volume":"165","author":"Vay","year":"2012","journal-title":"Br J Pharmacol"},{"issue":"4","key":"10.1016\/j.jcmgh.2020.10.001_bib44","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s00401-013-1099-4","article-title":"Neural plasticity in the gastrointestinal tract: chronic inflammation, neurotrophic signals, and hypersensitivity","volume":"125","author":"Demir","year":"2013","journal-title":"Acta Neuropathol"},{"issue":"4","key":"10.1016\/j.jcmgh.2020.10.001_bib45","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1136\/gut.2009.192567","article-title":"Potentiation of TRPV4 signalling by histamine and serotonin: an important mechanism for visceral hypersensitivity","volume":"59","author":"Cenac","year":"2010","journal-title":"Gut"},{"issue":"7","key":"10.1016\/j.jcmgh.2020.10.001_bib46","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1053\/j.gastro.2008.01.074","article-title":"Selective role for TRPV4 ion channels in visceral sensory\u00a0pathways","volume":"134","author":"Brierley","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jcmgh.2020.10.001_bib47","doi-asserted-by":"crossref","first-page":"68","DOI":"10.2174\/1876386301003010068","article-title":"Molecular Mechanisms of TRPV1 Channel Activation","volume":"3","author":"Jara-Oseguera","year":"2010","journal-title":"The Open Pain Journal"},{"issue":"1","key":"10.1016\/j.jcmgh.2020.10.001_bib48","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2174\/1871527311312010007","article-title":"Measurement of palmitoylethanolamide and other N-acylethanolamines during physiological and pathological conditions","volume":"12","author":"Balvers","year":"2013","journal-title":"CNS Neurol Disord Drug Targets"},{"issue":"2","key":"10.1016\/j.jcmgh.2020.10.001_bib49","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1007\/s12035-013-8487-6","article-title":"Glia and mast cells as targets for palmitoylethanolamide, an anti-inflammatory and neuroprotective lipid mediator","volume":"48","author":"Skaper","year":"2013","journal-title":"Mol Neurobiol"},{"issue":"1","key":"10.1016\/j.jcmgh.2020.10.001_bib50","doi-asserted-by":"crossref","first-page":"78","DOI":"10.2174\/1871527311312010013","article-title":"New insights in mast cell modulation by palmitoylethanolamide","volume":"12","author":"De Filippis","year":"2013","journal-title":"CNS Neurol Disord Drug Targets"},{"issue":"3","key":"10.1016\/j.jcmgh.2020.10.001_bib51","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1159\/000375454","article-title":"Increased cerebral cannabinoid-1 receptor availability is a stable feature of functional dyspepsia: a [F]MK-9470 PET study","volume":"84","author":"Ly","year":"2015","journal-title":"Psychother Psychosom"},{"key":"10.1016\/j.jcmgh.2020.10.001_bib52","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.phrs.2014.06.015","article-title":"Functional and biochemical interaction between PPAR\u03b1 receptors and TRPV1 channels: Potential role in PPAR\u03b1 agonists-mediated analgesia","volume":"87","author":"Ambrosino","year":"2014","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.jcmgh.2020.10.001_bib53","doi-asserted-by":"crossref","first-page":"5383","DOI":"10.1038\/s41598-018-23620-y","article-title":"Activation of Eosinophils and Mast Cells in Functional Dyspepsia: An Ultrastructural Evaluation","volume":"8","author":"Vanheel","year":"2018","journal-title":"Scientific Reports"},{"issue":"Suppl. s2","key":"10.1016\/j.jcmgh.2020.10.001_bib54","first-page":"17","article-title":"Duodenal low-grade inflammation and impaired mucosal integrity in functional dyspepsia patients","author":"Vanheel","year":"2012","journal-title":"Neurogastroenterol. Motil"},{"key":"10.1016\/j.jcmgh.2020.10.001_bib55","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1136\/gut.2005.071084","article-title":"Different contributions of ASIC channels 1a, 2, and 3 in gastrointestinal mechanosensory function","volume":"54","author":"Page","year":"2005","journal-title":"Gut"},{"key":"10.1016\/j.jcmgh.2020.10.001_bib56","first-page":"31","article-title":"Clinical endocannabinoid deficiency [CECD]: can this concept explain therapeutic benefits of cannabis in migraine, fibromyalgia, irritable bowel syndrome and other treatment-resistant conditions?","volume":"25","author":"Russo","year":"2004","journal-title":"Neuro Endocrinol Lett"},{"key":"10.1016\/j.jcmgh.2020.10.001_bib57","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1111\/j.1365-2982.2009.01299.x","article-title":"Intestinal immune activation in presumed post-infectious functional dyspepsia","volume":"21","author":"Kindt","year":"2009","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.jcmgh.2020.10.001_bib58","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/MCG.0b013e31815591f7","article-title":"Functional dyspepsia: not all roads seem to lead to rome","volume":"43","author":"van Kerkhoven","year":"2009","journal-title":"J Clin Gastroenterol"},{"issue":"7","key":"10.1016\/j.jcmgh.2020.10.001_bib59","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1111\/apt.13958","article-title":"Randomised clinical trial: the analgesic properties of dietary supplementation with palmitoylethanolamide and polydatin in irritable bowel syndrome","volume":"45","author":"Cremon","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"issue":"10","key":"10.1016\/j.jcmgh.2020.10.001_bib60","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1007\/s11136-004-9567-x","article-title":"Development and psychometric evaluation of the patient assessment of upper gastrointestinal symptom severity index (PAGI-SYM) in patients with functional gastrointestinal disease","volume":"13","author":"Rentz","year":"2004","journal-title":"Qual Life Res"},{"issue":"5","key":"10.1016\/j.jcmgh.2020.10.001_bib61","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0156198","article-title":"Palmitoylethanolamide Modulates Inflammation-Associated Vascular Endothelial Growth Factor (VEGF) Signaling via the Akt\/mTOR Pathway in a Selective Peroxisome Proliferator-Activated Receptor Alpha (PPAR-\u03b1)-Dependent Manner","volume":"11","author":"Sarnelli","year":"2016","journal-title":"Plos one"},{"key":"10.1016\/j.jcmgh.2020.10.001_bib62","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1002\/ptr.5601","article-title":"Antiproliferative and antiangiogenic effects of palmitoylethanolamide in Caco-2 human colon cancer cell involve a selective PPAR-alpha dependent inhibition of Akt\/mTOR pathway","volume":"30","author":"Sarnelli","year":"2016","journal-title":"Phytother. Res"},{"key":"10.1016\/j.jcmgh.2020.10.001_bib63","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1136\/gutjnl-2012-302090","article-title":"Enteroglial-derived S100B protein integrates bacteria-induced Toll-like receptor signalling in human enteric glial cells","volume":"63","author":"Turco","year":"2014","journal-title":"Gut"},{"issue":"11","key":"10.1016\/j.jcmgh.2020.10.001_bib64","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0027257","article-title":"High levels of N-palmitoylethanolamide and N-stearoylethanolamide in microdialysate samples from myalgic trapezius muscle in women","volume":"6","author":"Ghafouri","year":"2011","journal-title":"PLoS One"}],"container-title":["Cellular and Molecular Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352345X20301612?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352345X20301612?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T18:26:00Z","timestamp":1762453560000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352345X20301612"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"references-count":64,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021]]}},"alternative-id":["S2352345X20301612"],"URL":"https:\/\/doi.org\/10.1016\/j.jcmgh.2020.10.001","relation":{},"ISSN":["2352-345X"],"issn-type":[{"value":"2352-345X","type":"print"}],"subject":[],"published":{"date-parts":[[2021]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impaired Duodenal Palmitoylethanolamide Release Underlies Acid-Induced Mast Cell Activation in Functional Dyspepsia","name":"articletitle","label":"Article Title"},{"value":"Cellular and Molecular Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcmgh.2020.10.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Inc. on behalf of the AGA Institute.","name":"copyright","label":"Copyright"}]}}